Tranexamic acid reduces blood transfusion in surgical patients while its effects on thromboembolic events and mortality are uncertain

Evidence-Based Medicine

Volumn 18, Issue 2, 2013, Pages 65-66

  Raveendran, Raviraj ^a   Wong, Jean ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID;

ANEMIA; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DRUG ACTIVITY; DRUG EFFECT; HEART INFARCTION; HEART SURGERY; HUMAN; LUNG EMBOLISM; MORTALITY; NOTE; RISK ASSESSMENT; SEIZURE; SURGICAL PATIENT; THROMBOEMBOLISM;

EID: 85027920062     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/eb-2012-100872     Document Type: Note

References (4)

1. Tsui AKY, Dattani ND, Marsden PA, et al. Reassessing the risk of hemodilutional anemia: some new pieces to an old puzzle. Can J Anesth 2010;57:779-91.
2. Manji RA, Grocott HP, Leake J, et al. Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anesth 2012;59:6-13.
3. Horrow JC, Van Riper DF, Strong MD, et al. The dose-response relationship of tranexamic acid. Anesthesiology 1995;82:383-92.
4. Aspirin and tranexamic acid for coronary artery surgery-ATACASn (ACTRN12605000557636). http//www.anzctr. org.au/trial-view.aspx?id=789